A study to investigate how solifenacin fluid is taken up, how long it stays in the body and how effective and safe it is in treating children aged from 6 months to less than 5 years with symptoms of n...

Update Il y a 4 ans
Reference: EUCTR2012-003178-22

A study to investigate how solifenacin fluid is taken up, how long it stays in the body and how effective and safe it is in treating children aged from 6 months to less than 5 years with symptoms of neurogenic detrusor overactivity

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the long-term efficacy, safety, and pharmacokinetics (PK) of solifenacin succinate suspension after multiple dose administration.


Inclusion criteria

  • Neurogenic Detrusor Overactivity (NDO)